Osaic Holdings’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-275
Closed -$142 7642
2023
Q3
$142 Hold
275
﹤0.01% 7192
2023
Q2
$196 Sell
275
-100
-27% -$90 ﹤0.01% 7213
2023
Q1
$454 Hold
375
﹤0.01% 7148
2022
Q4
$0 Sell
375
-5
-1% -$6 ﹤0.01% 7770
2022
Q3
$1K Hold
380
﹤0.01% 7187
2022
Q2
$1K Hold
380
﹤0.01% 7256
2022
Q1
$2K Sell
380
-268
-41% -$1.36K ﹤0.01% 6968
2021
Q4
$5K Buy
648
+7
+1% +$80 ﹤0.01% 6711
2021
Q3
$10K Buy
641
+376
+142% +$6.36K ﹤0.01% 6253
2021
Q2
$6K Hold
265
﹤0.01% 6333
2021
Q1
$7K Buy
265
+260
+5,200% +$6.53K ﹤0.01% 6056
2020
Q4
$0 Sell
5
-1
-17% -$31 ﹤0.01% 6700
2020
Q3
$0 Hold
6
﹤0.01% 6525
2020
Q2
$0 Hold
6
﹤0.01% 6442
2020
Q1
$0 Buy
+6
New +$468 ﹤0.01% 6265

Other funds holding HSTO

Osaic Holdings's HSTO Position: Q4 2023 in Review

Osaic Holdings sold out of Histogen Inc. Common Stock (HSTO) in Q4 2023, closing a stake of 275 shares — an estimated $142 sold.

Osaic Holdings first reported a position in HSTO in Q1 2020 and held it in 15 quarters. The position peaked at $10K in Q3 2021. 1 fund tracked by Wall St. Rank holds HSTO as of Q4 2023.

  • Osaic Holdings reported no remaining Histogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Osaic Holdings sold 275 Histogen Inc. Common Stock shares in Q4 2023, an estimated $142.
  • Osaic Holdings first reported a position in Histogen Inc. Common Stock in Q1 2020 and held it in 15 quarters.
  • Osaic Holdings's Histogen Inc. Common Stock position peaked at $10K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.